The Lacosamide's Effect on Calcitonin Gene-related Peptide in Migraine Patients
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
We assessed serum CGRP concentrations in forty migraine patients according to the
International Classification of Headache Disorders 3rd edition aged 10-55 years with
migraines before and after receiving lacosamide 50 mg Bid for 3 months